BioCentury | Jul 19, 2010
Finance

FDA behind; IPO in front

...offering. Investors include Sofinnova Venture Partners (21.2% pre-IPO stake); InterWest Partners (17.7%); Versant Ventures (17.7%); Prism Venture Partners...
BioCentury | Nov 9, 2009
Finance

Ebb & Flow

...in cash. Investors include Sofinnova Venture Partners (21.3%, pre-IPO); InterWest Partners (17.7%); Versant Ventures (17.7%); Prism Venture Partners...
BioCentury | Feb 14, 2007
Financial News

Locus raises $30.2 million

...Blue Bell, Penn.) raised $30.2 million in a series D round led by Novartis Bioventures; Prism Venture Partners...
BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...Mass., and focus on both device and pharmaceutical companies. Previously, Weinstein was a principal at Prism Venture Partners...
BioCentury | May 15, 2006
Company News

Proteon board of directors update

...TVM Capital; David Lowe, a partner at Skyline Ventures; and Brendan O'Leary, a principal at Prism Venture Partners WIR...
BioCentury | Mar 31, 2006
Financial News

Proteon raises $19 million

...raised $19 million in a series A round led by TVM Capital and Skyline Ventures. Prism Venture Partners...
BioCentury | Jul 16, 2005
Financial News

Peptimmune raises $20.4 million

...investors Itochu and Silicon Valley Bank Capital joined existing investors New Enterprise Associates; MPM Capital; Prism Venture Partners...
BioCentury | Jan 31, 2005
Finance

Ebb & Flow

...diagnostics, wireless communications and other technologies. The firm has E600 million ($782.9 million) under management. Prism Venture Partners...
BioCentury | Mar 15, 2004
Finance

Ebb & Flow

...Ventures. Protein engineering company BioRexis raised $30 million in a series B round co-led by Prism Venture Partners...
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Research Foundation's Genomics Institute Peptimmune $41.2 3/12/03 Autoimmune; inflammation U.S. New Enterprise Associates; MPM Capital; Prism Venture Partners...
Items per page:
1 - 10 of 27
BioCentury | Jul 19, 2010
Finance

FDA behind; IPO in front

...offering. Investors include Sofinnova Venture Partners (21.2% pre-IPO stake); InterWest Partners (17.7%); Versant Ventures (17.7%); Prism Venture Partners...
BioCentury | Nov 9, 2009
Finance

Ebb & Flow

...in cash. Investors include Sofinnova Venture Partners (21.3%, pre-IPO); InterWest Partners (17.7%); Versant Ventures (17.7%); Prism Venture Partners...
BioCentury | Feb 14, 2007
Financial News

Locus raises $30.2 million

...Blue Bell, Penn.) raised $30.2 million in a series D round led by Novartis Bioventures; Prism Venture Partners...
BioCentury | Dec 4, 2006
Finance

Ebb & Flow

...Mass., and focus on both device and pharmaceutical companies. Previously, Weinstein was a principal at Prism Venture Partners...
BioCentury | May 15, 2006
Company News

Proteon board of directors update

...TVM Capital; David Lowe, a partner at Skyline Ventures; and Brendan O'Leary, a principal at Prism Venture Partners WIR...
BioCentury | Mar 31, 2006
Financial News

Proteon raises $19 million

...raised $19 million in a series A round led by TVM Capital and Skyline Ventures. Prism Venture Partners...
BioCentury | Jul 16, 2005
Financial News

Peptimmune raises $20.4 million

...investors Itochu and Silicon Valley Bank Capital joined existing investors New Enterprise Associates; MPM Capital; Prism Venture Partners...
BioCentury | Jan 31, 2005
Finance

Ebb & Flow

...diagnostics, wireless communications and other technologies. The firm has E600 million ($782.9 million) under management. Prism Venture Partners...
BioCentury | Mar 15, 2004
Finance

Ebb & Flow

...Ventures. Protein engineering company BioRexis raised $30 million in a series B round co-led by Prism Venture Partners...
BioCentury | Mar 15, 2004
Finance

'A' for effort

...Research Foundation's Genomics Institute Peptimmune $41.2 3/12/03 Autoimmune; inflammation U.S. New Enterprise Associates; MPM Capital; Prism Venture Partners...
Items per page:
1 - 10 of 27